Rare diseases
Investigational molecules
Locations
Building 1 Room 901 9th Floor, No 367 Shengrong Road, Shanghai Pilot Free Trade Zone, 201210
Clinical development activity includes treatment research in locally advanced and metastatic gastroesophageal junction cancer and gastric cancer, with attention to HER2-directed therapy and combination regimens used in first-line care.
Research in this area is centered on antibody-based treatment strategies integrated with established chemotherapy backbones and immunotherapy-relevant combinations.
Shanghai Henlius Biotech Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Gastric cancer, Oesophageal carcinoma, Oesophageal cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
FranceStudy of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer
GermanyEvaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
